Skip to main navigation Skip to search Skip to main content

Multivesicular liposome (Depofoam) in human diseases

  • Bahare Salehi
  • , Abhay P. Mishra
  • , Manisha Nigam
  • , Farzad Kobarfard
  • , Zeeshan Javed
  • , Sadegh Rajabi
  • , Khushbukhat Khan
  • , Hafiz Ahsan Ashfaq
  • , Toqeer Ahmad
  • , Raffaele Pezzani
  • , Karina Ramírez-Alarcón
  • , Miquel Martorell
  • , William C. Cho
  • , Seyed Abdulmajid Ayatollahi
  • , Javad Sharifi-Rad
  • Bam University of Medical Sciences
  • Hemwati Nandan Bahuguna Garhwal University
  • Shahid Beheshti University of Medical Sciences
  • Lahore Garrison University
  • National University of Sciences and Technology Pakistan
  • University of Padua
  • Associazione Italiana per la Ricerca Oncologica di Base
  • Universidad de Concepción
  • Queen Elizabeth Hospital Hong Kong

Research output: Contribution to journal › Review article › peer-review

40 Scopus citations

Abstract

Drug development is a key point in the research of new therapeutic treatments for increasing maximum drug loading and prolonged drug effect. Encapsulation of drugs into multivesicular liposomes (DepoFoam) is a nanotechnology that allow delivery of the active constituent at a sufficient concentration during the entire treatment period. This guarantees the reduction of drug administration frequency, a very important factor in a prolonged treatment. Currently, diverse DepoFoam drugs are approved for clinical use against neurological diseases and for post-surgical pain management while other are under development for reducing surgical bleeding and for post-surgical analgesia. Also, on pre-clinical trials on cancer DepoFoam can improve bioavailability and stability of the drug molecules minimizing side effects by site-specific targeted delivery. In the current work, available literature on structure, preparation and pharmacokinetics of DepoFoam are reviewed. Moreover, we investigated approved DepoFoam formulations and preclinical studies with this nanotechnology.

Original languageEnglish
Pages (from-to)9-21
Number of pages13
JournalIranian Journal of Pharmaceutical Research
Volume19
Issue number2
DOIs
StatePublished - 2020
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • DepoFoam
  • Depocyt
  • Drugs
  • Encapsulation
  • Nanotechnology

Fingerprint

Dive into the research topics of 'Multivesicular liposome (Depofoam) in human diseases'. Together they form a unique fingerprint.

Cite this